T. Rowe Price Small Cap ETF
TSEE - ETF AI Analysis
Top Page
T. Rowe Price Small Cap ETF (TSEE)
TSEE, the T. Rowe Price Small Cap ETF, earns a solid overall rating driven by several financially strong and strategically well-positioned holdings like InterDigital, TMX Group, Repligen, Osisko Gold Royalties, PrairieSky Royalty, and BrightSpring Health Services, which contribute stable performance, growth, and positive sentiment despite some valuation concerns. The fund’s rating is held back somewhat by weaker names such as Dyne Therapeutics, Grocery Outlet, and Oscar Health, where profitability, cash flow, and bearish technical trends pose challenges. The main risk factor is exposure to multiple companies with high valuations or profitability pressures, which can make the ETF more sensitive to market volatility and earnings disappointments.
TSEE vs. SPDR S&P 500 ETF (SPY)
- AUM
- 10.70M
- Region
- North America
- Expense Ratio
- 0.59%
- Beta
- 0.39
- Issuer
- T. Rowe Price
- Inception Date
- Sep 17, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
TSEE Summary
The T. Rowe Price Small Cap ETF (TSEE) is an actively managed fund that focuses on smaller U.S. companies, rather than tracking a set index. It spreads investments across many industries, including health care, financials, and industrials, with top holdings like Dyne Therapeutics and Grocery Outlet. Someone might invest in TSEE to seek long-term growth and diversify beyond large, well-known stocks by adding smaller, up-and-coming businesses. However, because it invests in small companies, the share price can be more volatile and may rise and fall more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.59%, which means you’ll pay about $5.90 per year for every $1,000 you invest. That’s higher than the average index ETF because this fund is actively managed, where professional managers research and select small-cap stocks rather than simply tracking a benchmark.
What would affect this ETF?
This ETF could benefit if the U.S. economy stays healthy, small-cap companies regain investor interest, and sectors like health care, financials, and industrials see steady growth or supportive regulations that help smaller businesses expand. On the other hand, rising interest rates, an economic slowdown in the U.S., or setbacks in health care and energy companies could hurt many of its holdings and make the fund more volatile than large-cap-focused investments.
TSEE Top 10 Holdings
TSEE leans heavily into U.S. small caps with a clear tilt toward health care and financial names, and a dash of Canadian exposure through TMX Group and PrairieSky Royalty. Oscar Health and BrightSpring Health Services have been rising sharply, helping power the fund’s recent momentum, while Repligen and InterDigital add steady, tech-leaning support after mixed stretches. On the other side, Dyne Therapeutics has been lagging, and Osisko Gold Royalties has lost some shine, modestly dragging on returns. Overall, a concentrated bet on smaller, more volatile growth stories.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Liberty Media Corp. Series C Liberty Live | 2.14% | $230.80K | $9.66B | 26.10% | ―― | |
| Dyne Therapeutics | 1.89% | $204.23K | $3.22B | -8.87% | 43Neutral | |
| TMX Group | ― | ― | ― | ― | 70Outperform | |
| Grocery Outlet Holding | 1.53% | $164.95K | $1.25B | 13.05% | 52Neutral | |
| Mirion Technologies | 1.47% | $159.07K | $4.36B | -26.14% | 66Neutral | |
| Oscar Health | 1.40% | $151.55K | $9.58B | 122.58% | 49Neutral | |
| InterDigital | 1.37% | $148.02K | $7.43B | -16.55% | 76Outperform | |
| OR Royalties | ― | ― | ― | ― | 70Outperform | |
| Pinnacle Financial Partners | 1.26% | $136.11K | $15.27B | 15.00% | 73Outperform | |
| Planet Fitness | 1.23% | $133.17K | $4.62B | -42.88% | 70Outperform |
TSEE Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TSEE, the sentiment is Positive. The current price of 25.14 is above the 20-day moving average (MA) of 24.87, compared to the 50-day MA of , and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.14 indicates Negative momentum. The RSI at 52.67 is Neutral, neither overbought nor oversold. The STOCH value of 77.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSEE.
TSEE Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $25.14 | $26.00(3.41% Upside) | $10.70M | 0.59% | 60Neutral | |
| $36.71 | $50.48(37.52% Upside) | $84.23M | 0.64% | 64Neutral | |
| $26.69 | $33.96(27.24% Upside) | $82.55M | 0.75% | 65Neutral | |
| $29.03 | $37.03(27.57% Upside) | $60.09M | 0.61% | 66Neutral | |
| $28.58 | $37.99(32.94% Upside) | $33.51M | 0.49% | 66Neutral | |
| $19.70 | $24.31(23.39% Upside) | $25.59M | 0.86% | 64Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSEE | T. Rowe Price Small Cap ETF | 25.14 | -0.08 | -0.33% | |
| RUSC | US Small Cap Equity Active ETF | 36.71 | 7.51 | 25.71% | |
| AIMS | Acuitas Small Cap Active ETF | 26.68 | 1.50 | 5.98% | |
| SYZ | Lazard US Systematic Small Cap Equity ETF | 29.02 | 5.48 | 23.30% | |
| ESSC | Eventide Small Cap ETF | 28.58 | 4.54 | 18.90% | |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 19.70 | 3.17 | 19.16% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
